Dynavax to Participate at the 8th Annual Evercore Healthcare Conference
Dynavax (Nasdaq: DVAX) will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025 at 2:10 p.m. ET. The presentation will be webcast and available on the company’s Investors > Events & Presentations page.
Dynavax is a commercial-stage biopharmaceutical company with two commercial products: HEPLISAV-B (Hepatitis B vaccine) and the CpG 1018 adjuvant, used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines.
Dynavax (Nasdaq: DVAX) parteciperà a una chiacchierata informale durante la 8ª Conferenza Annuale Evercore sull''assistenza sanitaria martedì 2 dicembre 2025 alle ore 14:10 ET. La presentazione sarà trasmessa in webcast e disponibile sulla pagina Investitori > Eventi & Presentazioni dell''azienda.
Dynavax è una società biofarmaceutica in fase commerciale con due prodotti commerciali: HEPLISAV-B (vaccino contro l''epatite B) e l''adiuvante CpG 1018, utilizzato in HEPLISAV-B e in diversi vaccini COVID-19 adiuvati.
Dynavax (Nasdaq: DVAX) participará en una charla informal en la 8th Annual Evercore Healthcare Conference el martes 2 de diciembre de 2025 a las 2:10 p.m. ET. La presentación será transmitida por webcast y estará disponible en la página de la empresa Investors > Events & Presentations.
Dynavax es una compañía biofarmacéutica en fase comercial con dos productos comerciales: HEPLISAV-B (vacuna contra la hepatitis B) y el adyuvante CpG 1018, utilizado en HEPLISAV-B y en varias vacunas COVID-19 adyuvadas.
Dynavax (나스닥: DVAX)는 제8회 Evercore 헬스케어 컨퍼런스의 파이어사이드 채팅에 2025년 12월 2일 화요일 동부 표준시 14:10에 참여합니다. 발표는 웹캐스트로 중계되며 회사의 투자자 페이지 > 이벤트 및 발표에서 확인할 수 있습니다.
Dynavax는 두 가지 상용 단계의 생물의약품을 보유한 상용 기업으로, 두 가지 상용 제품은 HEPLISAV-B (B형 간염 백신)와 CpG 1018 보조제로, HEPLISAV-B 및 다수의 보조 COVID-19 백신에 사용됩니다.
Dynavax (Nasdaq: DVAX) participera à une discussion informelle lors de la 8e Conférence annuelle Evercore sur les soins de santé le mardi 2 décembre 2025 à 14h10 ET. La présentation sera diffusée en webcast et disponible sur la page Investors > Events & Presentations de l''entreprise.
Dynavax est une société biopharmaceutique en phase commerciale avec deux produits commerciaux : HEPLISAV-B (vaccin contre l’hépatite B) et l’adjuvant CpG 1018, utilisé dans HEPLISAV-B et dans plusieurs vaccins COVID-19 adjuvantés.
Dynavax (Nasdaq: DVAX) wird an einem informellen Gespräch bei der 8. Jahrestagung der Evercore Healthcare Conference am Dienstag, 2. Dezember 2025, um 14:10 Uhr ET teilnehmen. Die Präsentation wird im Webcast übertragen und ist auf der Investors > Events & Presentations-Seite des Unternehmens verfügbar.
Dynavax ist ein biopharmazeutisches Unternehmen in der kommerziellen Phase mit zwei kommerziellen Produkten: HEPLISAV-B (Hepatitis-B-Impfstoff) und dem Adjuvans CpG 1018, das in HEPLISAV-B und in mehreren adjuvantierten COVID-19-Impfstoffen verwendet wird.
داينافيكس (بورصة ناسداك: DVAX) ستشارك في دردشة fireside في المؤتمر السنوي الثامن Evercore للرعاية الصحية يوم الثلاثاء 2 ديسمبر 2025 في الساعة 2:10 مساءً بتوقيت شرق الولايات المتحدة. سيُبث العرض عبر الويب ومتاح على صفحة الشركة المستثمرون > الأحداث & العروض.
داينافيكس هي شركة أحياء دوائية في مرحلة التشغيل التجاري مع منتجين تجاريين: HEPLISAV-B (لقاح التهاب الكبد B) و CpG 1018 المُعزِّز، المستخدم في HEPLISAV-B وفي عدة لقاحات COVID-19 المعزَّزة.
- None.
- None.
The presentations will be webcast and may be accessed through the "Events & Presentations" page on the "Investors" section of the Company's website at https://investors.dynavax.com/events-presentations.
About Dynavax
Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the
For Investors/Media:
Paul Cox
pcox@dynavax.com
510-665-0499
Nicole Arndt
narndt@dynavax.com
510-665-7264
View original content to download multimedia:https://www.prnewswire.com/news-releases/dynavax-to-participate-at-the-8th-annual-evercore-healthcare-conference-302620786.html
SOURCE Dynavax Technologies
FAQ
When will Dynavax (DVAX) present at the Evercore Healthcare Conference?
How can investors watch Dynavax's (DVAX) Evercore presentation on December 2, 2025?
What topics will Dynavax (DVAX) cover at the 8th Annual Evercore Healthcare Conference?
What is Dynavax's (DVAX) ticker and industry?
Which commercial products does Dynavax (DVAX) highlight ahead of the conference?
Who can investors contact for more information about Dynavax's (DVAX) conference participation?
